Tiptree Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • High gross margins
  • Robust FCF
  • Working-capital risk

AI
AI Summary

6.0

TIPT is best viewed not as an earnings compounder but as a balance-sheet/asset-realization play—pro‑forma book value (~$24.40) materially exceeds the market (~$16), creating upside if Fortegra/Reliance sale proceeds and receivable collections are independently verified. Monitor three specific catalysts: (1) confirmed cash receipts from disposals, (2) improving receivable/working‑capital trends, and (3) tangible opex reductions—or trim exposure immediately if reserve write‑downs, rising other comprehensive losses, or missed proceeds emerge.

BalanceSheet
ReserveRisk
Realization‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • High gross margins
  • Robust FCF
  • Working-capital risk

TIPT delivers strong gross margins and cash generation but thin net profitability, large receivables/contract liabilities, high opex and equity-sized leverage that weigh on valuation despite attractive EV/EBIT and P/E multiples.

StrongFCF
ReceivableRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below moving average
  • Near clear support
  • Lower highs/lows

TIPT is in a short-term downtrend—closing at $15.73 (a last-month low, ~7.5% below $17.00), ~4–5% beneath the last-month SMA (~$16.46) with immediate support at $15.73 and resistance near $17.11–$17.12, favoring cautious/defensive positioning given lower highs and lower lows.

bearish
Support Level: $15.73
Resistance Level: $17.11–$17.12

~7.5% decline from $17.00 since 2026-02-20 showing steady slide into

Sentiment & News

6.0

Key News Insights:

  • Pro-forma BV boost
  • Share-price gap
  • Active dealmaking

Tiptree said late-2025 asset sales would lift pro-forma book value to about $24.40/share, yet the stock fell to roughly $16 on Mar 8, highlighting a large valuation gap amid ongoing portfolio reshaping.

valuation
restructuring

Market skepticism about execution and near-term returns likely keeps the stock discounted until transactions close or clearer guidance is provided